David Ritchie

7.6k citations
201 papers · 4.2k · 1 hit paper · h-index 36

Impact in

  • Hematology top 0.5%
    • Multiple Myeloma Research and Treatments
    • Hematopoietic Stem Cell Transplantation
  • Oncology top 1%
    • CAR-T cell therapy research

Papers in

    • Hematopoietic Stem Cell Transplantation 42
    • Acute Myeloid Leukemia Research 32
    • Multiple Myeloma Research and Treatments 21
    • CAR-T cell therapy research 27

David Ritchie

190 papers receiving 4.1k citations

David Ritchie's Hit Papers

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma 2009 · 456 citations
4560+5+11Years since publication100200300400

Peers

David Ritchie
Comparison fields: 5 of 130
  • Hematology 1.2k
  • Oncology 1.6k
  • Genetics 509
  • Immunology 1.0k
  • Pathology and Forensic Medicine 813
Replace Yoshinobu Maeda with:
Yoshinobu Maeda Japan
Fiona E. Craig United States
Marie José Kersten Netherlands
Naoyuki Katayama Japan
Kikkeri N. Naresh United Kingdom
Hirokazu Kanegane Japan
Mehdi Hamadani United States
Ulrike Pötschger Austria
Lawrence G. Lum United States
Thomas A. Seemayer Canada
David Ritchie relative to Yoshinobu Maeda Japan Yoshinobu Maeda's profile →
Citations per field
00.5×1.5×
Yoshinobu Maeda · 1×
Citations per year

Countries citing papers authored by David Ritchie

Since Specialization
Citations

This map shows the geographic impact of David Ritchie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ritchie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ritchie more than expected).

Fields of papers citing papers by David Ritchie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Ritchie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ritchie. The network helps show where David Ritchie may publish in the future.

Co-authors

The 25 scholars most cited alongside David Ritchie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Ritchie Line = papers co-authored together David Ritchie links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 201 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma
Hit paper breakdown →
2009456
2 2018251
3 2014156
4 201098
5 201492
6 201284
7 201383
8 201970
9 201070
10 200969
11 201767
12 201466
13 200664
14 201763
15 201057
16 201557
17
Antigen expressed on tumor cells fails to elicit an immune response, even in the presence of increased numbers of tumor-specific cytotoxic T lymphocyte precursors.
199857
18 201854
19 201354
20 201351

About David Ritchie

David Ritchie is a scholar working on Hematology, Oncology, Immunology, Pathology and Forensic Medicine and Genetics, having authored 201 papers that have together received 4.2k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (42 papers), Acute Myeloid Leukemia Research (32 papers), Lymphoma Diagnosis and Treatment (32 papers), CAR-T cell therapy research (27 papers), Chronic Lymphocytic Leukemia Research (26 papers), Immune Cell Function and Interaction (24 papers), Multiple Myeloma Research and Treatments (21 papers) and Cytomegalovirus and herpesvirus research (19 papers). The work is most often cited by research in Hematology (1.2k citations), Oncology (1.6k citations), Genetics (509 citations), Immunology (1.0k citations) and Pathology and Forensic Medicine (813 citations). David Ritchie has collaborated with scholars based in Australia, New Zealand and United States. Frequent co-authors include H. Miles Prince, Paul J. Neeson, Simon J. Harrison, Mark J. Smyth, Hang Quach, A. Keith Stewart, John F. Seymour, Andrew Grigg, Jeff Szer and Monica A. Slavin. Their work appears in journals such as Blood, Bone Marrow Transplantation, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact